Condition
Blood Disorders
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Terminated1
Completed1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02218151Not ApplicableTerminatedPrimary
Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2
NCT02095951Phase 4Completed
Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection
NCT02461199UnknownPrimary
Stool Transplantation to Reduce Antibiotic Resistance Transmission
Showing all 3 trials